Recently, Teng et al. reported that the blockade of the programmed death ligand 1 (PD-L1) immune checkpoint pathway significantly enhanced the anti-tumor immune responses in hepatocellular carcinoma in mice and induced stronger CTL responses [24]. This evidence concerns the gene CD274 and neoplasm.